FAFCX
Price
$34.94
Change
-$0.47 (-1.33%)
Updated
Aug 15 closing price
Net Assets
683.93M
FIDSX
Price
$15.86
Change
-$0.21 (-1.31%)
Updated
Aug 15 closing price
Net Assets
1.09B
Interact to see
Advertisement

FAFCX vs FIDSX

Header iconFAFCX vs FIDSX Comparison
Open Charts FAFCX vs FIDSXBanner chart's image
Fidelity Advisor Financials C
Price$34.94
Change-$0.47 (-1.33%)
VolumeN/A
Net Assets683.93M
Fidelity Select Financials Port
Price$15.86
Change-$0.21 (-1.31%)
VolumeN/A
Net Assets1.09B
FAFCX vs FIDSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FAFCX vs. FIDSX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FAFCX is a Buy and FIDSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FIDSX has more cash in the bank: 1.09B vs. FAFCX (684M). FIDSX pays higher dividends than FAFCX: FIDSX (1.36) vs FAFCX (0.61). FAFCX was incepted earlier than FIDSX: FAFCX (28 years) vs FIDSX (44 years). FAFCX (1.75) is less costly to investors than FIDSX (0.69). FAFCX is a more actively managed with annual turnover of: 44.00 vs. FIDSX (35.00). FAFCX (0) and FIDSX (0) have matching initial minimum investment requirements. FAFCX annual gain was more profitable for investors over the last year : 19.06 vs. FIDSX (17.99). FAFCX (108.95) and FIDSX (108.34) have equivalent 5 years return.
FAFCXFIDSXFAFCX / FIDSX
Total Expense Ratio1.750.69254%
Annual Report Gross Expense Ratio1.750.69254%
Fund Existence28 years44 years-
Gain YTD7.8396.594119%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets684M1.09B63%
Annual Yield % from dividends0.611.3645%
Returns for 1 year19.0617.99106%
Returns for 3 years38.8440.2596%
Returns for 5 years108.95108.34101%
Returns for 10 years136.5693.48146%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARQT16.890.91
+5.69%
Arcutis Biotherapeutics
DRMA5.980.17
+2.93%
Dermata Therapeutics Inc
CART43.920.04
+0.10%
Maplebear
ASRT0.81-0.01
-0.64%
Assertio Holdings
WNC10.67-0.15
-1.39%
Wabash National Corp